bpc-157 tga approval status This is a joint statement from the and Australia's Chief Medical Officer on concerns regarding the public health risks associated with unapproved peptide products. Australia's health leaders are increasingly concerned about Injectable peptides: Where does the

The catch is that both slow digestion, so GI side effects can stack

Taking both together makes sense for most people, though folate status should be adequate before starting high-dose b12 to avoid masking folate deficiency

Annals of Internal Medicine

Neurological Health BPC-157 is also evidenced to have neuroprotective effects, reducing nerve damage due to strokes and injuries while regulating neurotransmitters to attenuate symptoms of Parkinsons disease, schizophrenia, and depression [2, 33, 36]

Will be reordering

It is not intended for human consumption, veterinary use, diagnostic procedures, cosmetic use, therapeutic applications, or medical treatment